Related Experiment Video
Updated: Feb 21, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans
Z E Belaya1, T A Grebennikova2, G A Melnichenko2
1The National Research Centre for Endocrinology, ul. Dmitria Uljanova, 11, Moscow, Russia, 117036. jannabelaya@gmail.com.
Abstract:
Hypercortisolism in humans suppresses osteoblastogenesis and osteoblast function through the upregulation of Wnt-signaling antagonists (sclerostin, Dkk1) and changes in microRNAs levels (miR-125b-5p, miR-218-5p, miR-34a-5p, miR-188-3p, miR-199a-5p) which are associated with mesenchymal stem-cell commitment to adipocytes or cartilage cells over the osteoblasts.
Introduction:
The purpose of this study was to evaluate the responses of bone to chronic glucocorticoid (GC) excess by measuring the levels of selected mRNA and microRNA (miR) in bone samples of patients with Cushing's disease (CD).
Methods:
Bone samples were obtained during transsphenoidal adenomectomy from the sphenoid bone (sella turcica) from 16 patients with clinically and biochemically evident CD and 10 patients with clinically non-functioning pituitary adenomas (NFPA) matched by sex, age, and body mass index. Quantitative polymerase chain reactions (qPCR) were used to examine the expression of genes (mRNA and miRs) known to be involved in bone remodeling regulation based on studies in animals and cell culture.
Results:
Hypercortisolism was associated with the downregulation of genes involved in osteoblast function and maturation (ACP5, ALPL, BGLAP, COL1A1, COL1A2, BMP2, RUNX2, TWIST1). An excess of GC caused increased expression of Wnt-signaling antagonists (Dkk1, SOST) and changes in the levels of miRs that are known to suppress osteoblastogenesis (miR-125b-5p, miR-218-5p, miR-34a-5p, miR-188-3p, miR-199a-5p) p < 0.05, q < 0.1. Interestingly, compensatory mechanisms were found in long-term hypercortisolism: upregulation of Wnt10b, LRP5, and LRP6; downregulation of SFRP4; changes in miRs involved in osteoblastogenesis (miR-210-5p, miR-135a-5p, miR-211, miR-23a-3p, miR-204-5p); and downregulation of genes associated with osteoclastogenesis. None of these changes prevented the suppression of bone formation.
Conclusions:
An excess of endogenous GC in humans suppresses bone formation through the upregulation of Wnt-signaling antagonists and dysregulation of miRs involved in mesenchymal stem-cell commitment. Both Wnt-signaling antagonists and miRs seem to be promising targets for further research in therapeutic intervention in glucocorticoid-induced osteoporosis.
Insights
Glucocorticoid excess in Cushing's disease suppresses bone formation by increasing Wnt antagonists and altering microRNAs, leading to reduced osteoblast function. These factors are potential therapeutic targets for glucocorticoid-induced osteoporosis.
Area of Science:
- Endocrinology
- Bone Biology
- Molecular Biology
Background:
- Hypercortisolism in humans impairs osteoblastogenesis and function.
- This is mediated by increased Wnt-signaling antagonists and altered microRNA levels.
- These microRNAs influence mesenchymal stem cell commitment towards adipocytes or cartilage over osteoblasts.
Purpose of the Study:
- To investigate bone responses to chronic glucocorticoid (GC) excess.
- To measure mRNA and microRNA (miR) levels in bone samples from Cushing's disease (CD) patients.
Main Methods:
- Bone samples were collected from CD patients and non-functioning pituitary adenoma (NFPA) controls during surgery.
- Quantitative polymerase chain reactions (qPCR) were used to analyze gene and miR expression.
- Focus was on genes and miRs involved in bone remodeling regulation.
Main Results:
- Hypercortisolism led to downregulation of osteoblast function genes (e.g., RUNX2, COL1A1).
- Increased expression of Wnt antagonists (Dkk1, SOST) and specific miRs suppressing osteoblastogenesis was observed.
- Compensatory mechanisms were noted in long-term hypercortisolism, but bone formation remained suppressed.
Conclusions:
- Endogenous GC excess suppresses bone formation via Wnt antagonists and dysregulated miRs.
- These molecular pathways impact mesenchymal stem cell differentiation.
- Wnt antagonists and miRs represent promising therapeutic targets for glucocorticoid-induced osteoporosis.
Related Concept Videos
MicroRNAs
MicroRNAs
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypothalamic-Pituitary Axis
